Cytokeratin 19 fragments: A new marker for non-small-cell lung cancer-Reference-Cited by-同舟云学术

Cytokeratin 19 fragments: A new marker for non-small-cell lung cancer

Published:1993-08 Issue:4 Volume:26 Page:301-304
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Stieber Petra,Bodenmüller Heinz,Banauch Dieter,Hasholzner Ute,Dessauer Andreas,Ofenloch-Hähnle Beatus,Jaworek Dieter,Fateh-Moghadam Ahmad

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference6 articles.

1. Cytokeratins in different types of human lung cancer as monitored by chainspecific monoclonal antibodies;Broers;Cancer Res,1988

2. CYERA—A new marker for non-small-cell lung cancer (NSCLC);Hasholzner,1992

3. CYFRA 21-1-A new marker in lung cancer;Stieber;Cancer,1993

4. Arbeitsgruppe Qualitätskontrolle und Standardisierung von Tumormarkertests in Rahmen der Hamburger Symposien über Tumormarker;Klapdor;Tumordiagnostik und Therapie,1992

5. Enzymun-Test® CYFRA 21-1, a new marker for NSCLC. Method evaluation and first clinical experiences;Bodenmüller;Clin Chem,1992

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing blood tumor marker concentrations in the absence of neoplasia;Tumor Biology;2024-03-19

2. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 − 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma;Journal of Gastrointestinal Cancer;2024-01-27

3. Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer;Clinical Laboratory;2024

4. Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events;Frontiers in Immunology;2023-12-12

5. Quantification of the lung cancer tumor marker CYFRA 21-1 using protein precipitation, immunoaffinity bottom-up LC-MS/MS;Clinical Chemistry and Laboratory Medicine (CCLM);2023-10-30